Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




HIV Protease Inhibitor Levels in Hair Predict Treatment Response
Link ID 14086
Title HIV Protease Inhibitor Levels in Hair Predict Treatment Response
Url http://www.medscape.com/viewarticle/589303?src=rss
Description Measuring levels of antiretroviral drugs in hair is superior to measuring plasma levels for assessment of drug exposure, US investigators report in the February 20 issue of AIDS. Furthermore, protease inhibitor concentrations in hair were the strongest independent predictor of virologic response to a new treatment. Reuters Health Information
Category Articles > HIV/AIDS
Keywords
Date Mar 11, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. HIV Risk Behaviors High Among Male Mexican Migrants
  Migration from Mexico to the U.S. appears to have a significant effect on increasing HIV high-risk behaviors among men, a study suggests. Reuters Health Information
Category:   Articles > HIV/AIDS


2. Infection With Mutated HIV May Offer Survival Advantage
  Individuals infected with a mutated strain of HIV, transmitted from a person possessing the HLA gene sequences that have allowed them to control the virus, may also have a survival advantage even if they do not possess the same gene sequences, AIDS researchers from South Africa report in the open-access online journal PLoS Pathogens. Reuters Health Information
Category:   Articles > HIV/AIDS


3. Switch From 3TC/ABC to FTC/TDF Maintains HIV SuppressionSwitch From 3TC/ABC to FTC/TDF Maintains HIV
  Patients with HIV can be switched from lamivudine/abacavir (3TC/ABC) to emtricitabine/tenofovir (FTC/TDF) to improve lipid profile and decrease risk for virologic failure. br / iMedscape Medical News/i
Category:   Articles > HIV/AIDS


4. 2010 National Summit on HIV Diagnosis, Prevention, and Access to Care
  Read clinically focused news coverage of key developments from the meeting. Medscape HIV/AIDS
Category:   Articles > HIV/AIDS


5. Once-Daily Darunavir Combo Better in HIV: FDA
  Some HIV patients can take darunavir/ritonavir once a day instead of twice a day, an international study has shown. Reuters Health Information
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS